BACKGROUND
Multiple sclerosis (MS) is a chronic neurological condition that imposes a significant burden on patients and healthcare systems.
OBJECTIVES
To estimate health utilities and costs of MS within the UK setting.
METHODS
Patients with MS recruited to the Trajectories of Outcomes in Neurological Conditions (T...
Yankier Pijeira Perez, Carolyn A. Young, R. Mills et al.· Value in Health· 0 citations
Abstract Introduction Economic evaluations conducted alongside clinical trials play a key role in informing healthcare decision-making. While structured validation frameworks are well established for model-based economic evaluations, there is no agreed approach to validating trial-based economic evaluations. Validation...
M. Png, K. Khan, Tracey H. Sach et al.· BMJ Open· 0 citations
With the accelerating growth in new RNA therapeutics, there needs to be consideration of the capacity for, and appropriateness of, current approaches of assessment and reimbursement, as well as the extent to which harmonisation of methods can support equitable and evidence-based access to patients across Europe.
Rasha A. Alshaikh, Diarmuid J. Cronin, Dyfrig A. Hughes et al.· European Journal of Pharmace...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.